(Q33737413)

29 July 2017

1 reference

title

Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease (English)

1 reference

29 July 2017

1 reference

Aronow WS

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

91-101

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

29 July 2017

cites work

1 reference

12 December 2020

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

12 December 2020

Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regime

1 reference

12 December 2020

Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disea

1 reference

12 December 2020

Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study

1 reference

12 December 2020

Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine après Pontage Fémoro-Poplité and the Association Universitaire de Recherche en Chirurgie

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group

1 reference

12 December 2020

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

12 December 2020

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

12 December 2020

Platelet-active drugs: the relationships among dose, effectiveness, and side effects

1 reference

12 December 2020

Results of EMATAP: a double-blind placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

12 December 2020

A prospective study of aspirin use and primary prevention of cardiovascular disease in women

1 reference

12 December 2020

The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins

1 reference

12 December 2020

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

12 December 2020

Cardiovascular and Renal Advisory Panel of the FDA

1 reference

12 December 2020

Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications

1 reference

12 December 2020

Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation

1 reference

12 December 2020

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

12 December 2020

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase

1 reference

12 December 2020

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

1 reference

12 December 2020

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

1 reference

12 December 2020

Effect of aspirin on mortality in women with symptomatic or silent myocardial ischemia. Israeli BIP Study Group

1 reference

12 December 2020

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

1 reference

12 December 2020

1 reference

12 December 2020

Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiolog

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial

1 reference

12 December 2020

Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study

1 reference

12 December 2020

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

12 December 2020

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group

1 reference

12 December 2020

Comparison of Effects of High-Dose and Low-Dose Aspirin on Restenosis After Femoropopliteal Percutaneous Transluminal Angioplasty

1 reference

12 December 2020

Clopidogrel for reduction of atherosclerotic events

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group

1 reference

12 December 2020

Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Dose-dependent effect of aspirin on carotid atherosclerosis

1 reference

12 December 2020

Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myoc

1 reference

12 December 2020

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

1 reference

12 December 2020

United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. UK-TIA Study Group

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

1 reference

12 December 2020

Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia

1 reference

12 December 2020

10.2165/00002512-199915020-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1030051226

0 references

1 reference